Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Randomized Noninferiority Trial of Telephone vs In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer: A 12-Month Follow-Up.

Interrante MK, Segal H, Peshkin BN, Valdimarsdottir HB, Nusbaum R, Similuk M, DeMarco T, Hooker G, Graves K, Isaacs C, Wood M, McKinnon W, Garber J, McCormick S, Heinzmann J, Kinney AY, Schwartz MD.

JNCI Cancer Spectr. 2017 Sep;1(1):pkx002. doi: 10.1093/jncics/pkx002. Epub 2017 Sep 22.

PMID:
31304457
2.

Decrease in energy expenditure in transportation.

DeMarco T.

Can Fam Physician. 2019 Jun;65(6):387. No abstract available.

3.

Cancer genetic health communication in families tested for hereditary breast/ovarian cancer risk: a qualitative investigation of impact on children's genetic health literacy and psychosocial adjustment.

Tercyak KP, Bronheim SM, Kahn N, Robertson HA, Anthony BJ, Mays D, O'Neill SC, Peterson SK, Miesfeldt S, Peshkin BN, DeMarco TA.

Transl Behav Med. 2019 May 16;9(3):493-503. doi: 10.1093/tbm/ibz012.

PMID:
31094441
4.

Increased predominance of HIV-1 CRF01_AE and its recombinants in the Philippines.

Chen Y, Hora B, DeMarco T, Berba R, Register H, Hood S, Carter M, Stone M, Pappas A, Sanchez AM, Busch M, Denny TN, Gao F.

J Gen Virol. 2019 Mar;100(3):511-522. doi: 10.1099/jgv.0.001198. Epub 2019 Jan 24.

PMID:
30676308
5.

Maternal perceptions of BRCA genetic counseling communication processes about disclosing cancer risk information to children and adult relatives.

Hamilton JG, Peshkin BN, Mays D, DeMarco TA, Patenaude AF, Tercyak KP.

Psychooncology. 2018 Jul;27(7):1825-1832. doi: 10.1002/pon.4733. Epub 2018 May 22.

6.

Who deserves basic rights? People condone violations of procedural and physical rights in the treatment of terrorist suspects.

Newheiser AK, DeMarco TC.

Law Hum Behav. 2018 Feb;42(1):50-56. doi: 10.1037/lhb0000275.

PMID:
29461077
7.

HIV Resistance and Prevention of Mother-to-Child Transmission Regimen in HIV-Infected Infants in Northern Tanzania.

Dow DE, Schimana W, Nyombi BM, Mmbaga BT, Shayo AM, Bartlett JA, Massambu CG, Kifaro EG, Turner EL, DeMarco T, Cai F, Cunningham CK, Buchanan AM.

AIDS Res Hum Retroviruses. 2017 Nov;33(11):1107-1113. doi: 10.1089/AID.2017.0025. Epub 2017 Oct 5.

8.

Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature.

Brondfield MN, Reid MJ, Rutishauser RL, Cope JR, Tang J, Ritter JM, Matanock A, Ali I, Doernberg SB, Hilts-Horeczko A, DeMarco T, Klein L, Babik JM.

Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12661. Epub 2017 Mar 6. Review.

9.

Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan.

Chen Y, Hora B, DeMarco T, Shah SA, Ahmed M, Sanchez AM, Su C, Carter M, Stone M, Hasan R, Hasan Z, Busch MP, Denny TN, Gao F.

PLoS One. 2016 Dec 14;11(12):e0167839. doi: 10.1371/journal.pone.0167839. eCollection 2016.

10.

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer.

Jacobs AS, Schwartz MD, Valdimarsdottir H, Nusbaum RH, Hooker GW, DeMarco TA, Heinzmann JE, McKinnon W, McCormick SR, Davis C, Forman AD, Lebensohn AP, Dalton E, Tully DM, Graves KD, Similuk M, Kelly S, Peshkin BN.

Fam Cancer. 2016 Oct;15(4):529-39. doi: 10.1007/s10689-016-9900-x.

11.

Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.

Hamilton JG, Mays D, DeMarco T, Tercyak KP.

Fam Cancer. 2016 Oct;15(4):513-22. doi: 10.1007/s10689-016-9876-6.

12.

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling.

Peshkin BN, Kelly S, Nusbaum RH, Similuk M, DeMarco TA, Hooker GW, Valdimarsdottir HB, Forman AD, Joines JR, Davis C, McCormick SR, McKinnon W, Graves KD, Isaacs C, Garber J, Wood M, Jandorf L, Schwartz MD.

J Genet Couns. 2016 Jun;25(3):472-82. doi: 10.1007/s10897-015-9897-6. Epub 2015 Oct 12.

13.

Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Benza RL, Gomberg-Maitland M, Demarco T, Frost AE, Torbicki A, Langleben D, Pulido T, Correa-Jaque P, Passineau MJ, Wiener HW, Tamari M, Hirota T, Kubo M, Tiwari HK.

Am J Respir Crit Care Med. 2015 Dec 1;192(11):1345-54. doi: 10.1164/rccm.201501-0196OC.

14.

Deleterious BRCA1/2 mutations in an urban population of Black women.

Lynce F, Smith KL, Stein J, DeMarco T, Wang Y, Wang H, Fries M, Peshkin BN, Isaacs C.

Breast Cancer Res Treat. 2015 Aug;153(1):201-9. doi: 10.1007/s10549-015-3527-8. Epub 2015 Aug 7.

15.

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.

Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD.

Genet Med. 2015 Jun;17(6):467-75. doi: 10.1038/gim.2014.125. Epub 2014 Sep 18.

16.

Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.

O'Neill SC, Mays D, Patenaude AF, Garber JE, DeMarco TA, Peshkin BN, Schneider KA, Tercyak KP.

J Community Genet. 2015 Jan;6(1):55-62. doi: 10.1007/s12687-014-0201-5. Epub 2014 Aug 7.

17.

Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.

Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1260-6. doi: 10.1158/1055-9965.EPI-13-0198.

18.

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Mays D, DeMarco TA, Luta G, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Tercyak KP.

Health Psychol. 2014 Aug;33(8):765-73. doi: 10.1037/a0033418. Epub 2013 Jun 24.

19.

Intentions for bilateral mastectomy among newly diagnosed breast cancer patients.

King L, O'Neill SC, Spellman E, Peshkin BN, Valdimarsdottir H, Willey S, Leventhal KG, DeMarco T, Nusbaum R, Feldman E, Jandorf L, Schwartz MD.

J Surg Oncol. 2013 Jun;107(7):772-6. doi: 10.1002/jso.23307. Epub 2012 Dec 27.

20.

Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and design.

Abraham WT, Anand I, Aranda JM Jr, Boehmer J, Costanzo MR, DeMarco T, Holcomb R, Ivanhoe R, Kolber M, Rayburn B.

Am Heart J. 2012 Nov;164(5):638-45. doi: 10.1016/j.ahj.2012.07.015. Epub 2012 Oct 2.

PMID:
23137493
21.

Talking to children about maternal BRCA1/2 genetic test results: a qualitative study of parental perceptions and advice.

Farkas Patenaude A, DeMarco TA, Peshkin BN, Valdimarsdottir H, Garber JE, Schneider KA, Hewitt L, Hamilton J, Tercyak KP.

J Genet Couns. 2013 Jun;22(3):303-14. doi: 10.1007/s10897-012-9549-z. Epub 2012 Oct 24.

22.

World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation.

Fang JC, DeMarco T, Givertz MM, Borlaug BA, Lewis GD, Rame JE, Gomberg-Maitland M, Murali S, Frantz RP, McGlothlin D, Horn EM, Benza RL.

J Heart Lung Transplant. 2012 Sep;31(9):913-33. doi: 10.1016/j.healun.2012.06.002. Review. Erratum in: J Heart Lung Transplant. 2013 Feb;32(2):275.

PMID:
22884380
23.

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.

Mays D, Sharff ME, DeMarco TA, Williams B, Beck B, Sheppard VB, Peshkin BN, Eng-Wong J, Tercyak KP.

Fam Cancer. 2012 Sep;11(3):493-502. doi: 10.1007/s10689-012-9541-7.

24.

Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial.

Costanzo MR, Ivanhoe RJ, Kao A, Anand IS, Bank A, Boehmer J, Demarco T, Hergert CM, Holcomb RG, Maybaum S, Sun B, Vassiliades TA Jr, Rayburn BK, Abraham WT.

J Card Fail. 2012 Jun;18(6):446-58. doi: 10.1016/j.cardfail.2012.04.004.

PMID:
22633302
25.

Genetic testing: the bigger picture.

Peshkin BN, Demarco TA.

Oncology (Williston Park). 2012 May 15;26(5). pii: 168243. No abstract available.

26.

Results of an online community needs assessment for psychoeducational interventions among partners of hereditary breast cancer previvors and survivors.

Tercyak KP, Mays D, DeMarco TA, Sharff ME, Friedman S.

J Med Internet Res. 2012 Jan 18;14(1):e15. doi: 10.2196/jmir.1847.

27.

Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.

Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP.

Genet Test Mol Biomarkers. 2012 May;16(5):376-82. doi: 10.1089/gtmb.2011.0154. Epub 2011 Nov 15.

28.

Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.

Hooker GW, Leventhal KG, DeMarco T, Peshkin BN, Finch C, Wahl E, Joines JR, Brown K, Valdimarsdottir H, Schwartz MD.

Med Decis Making. 2011 May-Jun;31(3):412-21. doi: 10.1177/0272989X10381283. Epub 2010 Sep 27.

29.

BRCA1/2 test results impact risk management attitudes, intentions, and uptake.

O'Neill SC, Valdimarsdottir HB, Demarco TA, Peshkin BN, Graves KD, Brown K, Hurley KE, Isaacs C, Hecker S, Schwartz MD.

Breast Cancer Res Treat. 2010 Dec;124(3):755-64. doi: 10.1007/s10549-010-0881-4. Epub 2010 Apr 10.

30.

The alpha-1D Is the predominant alpha-1-adrenergic receptor subtype in human epicardial coronary arteries.

Jensen BC, Swigart PM, Laden ME, DeMarco T, Hoopes C, Simpson PC.

J Am Coll Cardiol. 2009 Sep 22;54(13):1137-45. doi: 10.1016/j.jacc.2009.05.056.

31.

Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.

Rini C, O'Neill SC, Valdimarsdottir H, Goldsmith RE, Jandorf L, Brown K, DeMarco TA, Peshkin BN, Schwartz MD.

Health Psychol. 2009 Sep;28(5):569-578. doi: 10.1037/a0015205.

32.

On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.

Peshkin BN, Demarco TA, Tercyak KP.

Fam Cancer. 2010 Mar;9(1):89-97. doi: 10.1007/s10689-009-9267-3. Epub 2009 Jul 17.

33.

Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.

Demarco TA, Nusbaum RH, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Tercyak KP.

Patient Educ Couns. 2010 Jan;78(1):29-33. doi: 10.1016/j.pec.2009.05.013. Epub 2009 Jul 9.

34.

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Schwartz MD, Valdimarsdottir HB, DeMarco TA, Peshkin BN, Lawrence W, Rispoli J, Brown K, Isaacs C, O'Neill S, Shelby R, Grumet SC, McGovern MM, Garnett S, Bremer H, Leaman S, O'Mara K, Kelleher S, Komaridis K.

Health Psychol. 2009 Jan;28(1):11-19. doi: 10.1037/a0013147.

35.

Changes in diet and physical activity following BRCA1/2 testing.

O'Neill SC, Kaufman E, DeMarco T, Peshkin BN, McKenna K, Shelby R, Valdimarsdottir H, Rispoli J, Schwartz MD.

J Psychosoc Oncol. 2008;26(3):63-80.

PMID:
19042265
36.

Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.

Zhang B, Fackenthal JD, Niu Q, Huo D, Sveen WE, DeMarco T, Adebamowo CA, Ogundiran T, Olopade OI.

Fam Cancer. 2009;8(1):15-22. doi: 10.1007/s10689-008-9205-9. Epub 2008 Aug 5.

PMID:
18679828
37.

Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).

Peshkin BN, DeMarco TA, Garber JE, Valdimarsdottir HB, Patenaude AF, Schneider KA, Schwartz MD, Tercyak KP.

J Pediatr Psychol. 2009 Jul;34(6):627-38. doi: 10.1093/jpepsy/jsn033. Epub 2008 Apr 1.

38.

Telephone genetic counseling for high-risk women undergoing BRCA1 and BRCA2 testing: rationale and development of a randomized controlled trial.

Peshkin BN, Demarco TA, Graves KD, Brown K, Nusbaum RH, Moglia D, Forman A, Valdimarsdottir H, Schwartz MD.

Genet Test. 2008 Mar;12(1):37-52. doi: 10.1089/gte.2006.0525.

PMID:
18373403
39.

Role of parenting relationship quality in communicating about maternal BRCA1/2 genetic test results with children.

DeMarco TA, Peshkin BN, Valdimarsdottir HB, Patenaude AF, Schneider KA, Tercyak KP.

J Genet Couns. 2008 Jun;17(3):283-7. doi: 10.1007/s10897-007-9147-7. Epub 2008 Feb 21.

40.

Predictors of enrollment into a familial cancer registry by individuals at high risk for BRCA1/2.

Graves KD, Moss LM, Jasper CL, DeMarco TA, Peshkin BN, Isaacs C, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2763-7.

41.

Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.

Ghali JK, Boehmer J, Feldman AM, Saxon LA, Demarco T, Carson P, Yong P, Galle EG, Leigh J, Ecklund FL, Bristow MR.

J Card Fail. 2007 Nov;13(9):769-73.

PMID:
17996827
42.

Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD.

Genet Test. 2007 Fall;11(3):249-55.

43.

Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.

Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, PiƱa IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM.

Arch Intern Med. 2007 Oct 8;167(18):1998-2005.

PMID:
17923601
44.

Practical aspects of delivering hereditary cancer risk counseling.

DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C.

Semin Oncol. 2007 Oct;34(5):369-78. Review.

PMID:
17920890
45.

Life after BRCA1/2 testing: family communication and support issues.

DeMarco TA, McKinnon WC.

Breast Dis. 2006-2007;27:127-36. Review.

PMID:
17917144
46.

Genetic counseling about reproductive options for hereditary cancer: what is the standard of care?

Peshkin BN, Nusbaum RH, DeMarco TA.

J Clin Oncol. 2007 Mar 1;25(7):911-2; author reply 913. No abstract available.

PMID:
17327618
47.

Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.

Lindenfeld J, Feldman AM, Saxon L, Boehmer J, Carson P, Ghali JK, Anand I, Singh S, Steinberg JS, Jaski B, DeMarco T, Mann D, Yong P, Galle E, Ecklund F, Bristow M.

Circulation. 2007 Jan 16;115(2):204-12. Epub 2006 Dec 26.

PMID:
17190867
48.

Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.

Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV.

Am Heart J. 2007 Jan;153(1):98-104.

PMID:
17174645
49.

Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.

Tercyak KP, Peshkin BN, Brogan BM, DeMarco T, Pennanen MF, Willey SC, Magnant CM, Rogers S, Isaacs C, Schwartz MD.

J Clin Oncol. 2007 Jan 20;25(3):285-91. Epub 2006 Dec 11.

PMID:
17159191
50.

Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.

Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD.

Breast Cancer Res Treat. 2007 Sep;104(3):321-9. Epub 2006 Oct 26.

Supplemental Content

Loading ...
Support Center